Clinical Trials Browser

OTHER × ibrutinib × Genitourinary × Clear all

NCT02899078 2025-05-18

Ibrutinib and Nivolumab in Treating Patients With Previously-Treated Metastatic Kidney Cancer

Phase 1/2 Completed

31 enrolled 11 charts

Carcinoma, Renal Cell

NCT02643667 2025-01-08

Ibrutinib as Neoadjuvant Therapy in Localized Prostate Cancer

Phase 2 Completed

27 enrolled 11 charts

Prostatic Neoplasms